Instrument Inactif

Communiqués ScandiDos AB Nasdaq Stockholm

Actions

Cours en clôture Nasdaq Stockholm Autres places de cotation
- ^SEK	-

13/03	ScandiDos AB (publ) annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 janvier 2024	CI
2023	ScandiDos reçoit des commandes d'une valeur de 478 000 euros en provenance de Chine	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Successful user meeting in Madrid highlights ScandiDos' innovative solutions	18/04	AQ
ScandiDos receives orders worth €478 000 from China	20/12	AQ
ScandiDos AB changes Certified Adviser and liquidity provider to Carnegie Investment Bank AB (publ)	30/11	AQ
ScandiDos achieves EU Medical Device Regulation certification for the Delta4 Phantom+ product line	29/11	AQ
ScandiDos receives orders worth €290 000 from China	28/06/23	AQ
ScandiDos and IBA Dosimetry deepen strategic alliance!	13/05/23	AQ
ScandiDos receives an order worth €263 000 from China	14/03/23	AQ
ScandiDos sees growing demand for patient-specific QA in Chinese market	23/02/23	AQ
ScandiDos receives an order of € 377 500 from Japan	01/11/22	AQ
ScandiDos’ directed share issue completed	02/09/22	AQ
ScandiDos has completed a directed share issue of 4,150,000 shares at a subscription price of SEK 3 per share	30/08/22	AQ
ScandiDos launches Delta4 Insight which is immediately available to sell to customers in Europe and parts of Asia.	25/02/22	AQ
ScandiDos : celebrates 20 years of success	16/02/22	PU
ScandiDos Celebrates 20th Anniversary	16/02/22	AQ
ScandiDos : Delårsrapport för perioden 1 maj 2021 – 31 jul 2021	23/09/21	PU
ScandiDos : selected as preferred QA partner by first Radixact® Synchrony®customer in France	05/07/21	PU
ScandiDos : joins forces with Accuray to take motion synchronization QA to the next level	08/06/21	PU
ScandiDos : Leading centers all over the world select Scandidos' Delta4 Phantom+ MR for their MR-linac programs	04/03/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.

PROFITEZ-EN MAINTENANT